Next Article in Journal
Dasatinib for a Child with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia and Persistently Elevated Minimal Residual Disease during Imatinib Therapy
Previous Article in Journal
The Organization of Colposcopy Services in Ontario: Recommended Framework
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 22
Issue 4
10.3747/co.22.2690
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Communication

Recent Trends in Breast, Cervical, and Colorectal Cancer Screening Test Utilization in Canada, Using Self-Reported Data from 2008 and 2012

by
D. Major
1,2,
D. Armstrong
3,
H. Bryant
1,4,
W. Cheung
5,
K. Decker
6,
G. Doyle
7,
V. Mai
1,
C.M. McLachlin
8,
J Niu
1,
J. Payne
9 and
N. Shukla
1,*
1
Canadian Partnership Against Cancer, Toronto, ON, Canada
2
Département médecine sociale et préventive, Université Laval, Quebec, QC, Canada
3
Division of Gastroenterology, McMaster University Medical Centre, Hamilton, ON, Canada
4
Departments of Community Health Sciences and Oncology, University of Calgary, Calgary, AB, Canada
5
Division of Medical Oncology, BC Cancer Agency, and Department of Medicine, University of British Columbia, Vancouver, BC, Canada
6
CancerCare Manitoba and University of Manitoba, Winnipeg, MB, Canada
7
Breast Screening Program for Newfoundland and Labrador, St. John’s, NL, Canada
8
Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada
9
Department of Diagnostic Radiology, Dalhousie University, and Nova Scotia Breast Screening Program, Halifax, NS, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(4), 297-302; https://doi.org/10.3747/co.22.2690
Submission received: 4 May 2015 / Revised: 7 June 2015 / Accepted: 6 July 2015 / Published: 1 August 2015

Abstract

In Canada, self-reported data from the Canadian Community Health Survey 2008 and 2012 provide an opportunity to examine overall utilization of breast, cervical, and colorectal cancer screening tests for both programmatic and opportunistic screening. Among women 50–74 years of age, utilization of screening mammography was stable (62.0% in 2008 and 63.0% in 2012). Pap test utilization for women 25–69 years of age remained high and stable across Canada in 2008 and 2012 (78.9% in 2012). The percentage of individuals 50–74 years of age who reporting having at least 1 fecal test within the preceding 2 years increased in 2012 (to 23.0% from 16.9% in 2008), but remains low. Stable rates of screening mammography utilization (about 30%) were reported in 2008 and 2012 among women 40–49 years of age, a group for which population-based screening is not recommended. Although declining over time, cervical cancer screening rates were high for women less than 25 years of age (for whom screening is not recommended). Interestingly, an increased percentage of women 70–74 years of age reported having a Pap test. In 2012, a smaller percentage of women 50–69 years of age reported having no screening test (5.9% vs. 8.5% in 2008), and more women reported having the three types of cancer screening tests (19.0% vs. 13.2%). Efforts to encourage use of screening within the recommended average-risk age groups are needed, and education for stakeholders about the possible harms of screening outside those age groups has to continue.
Keywords: cancer screening; trends cancer screening; trends

Share and Cite

MDPI and ACS Style

Major, D.; Armstrong, D.; Bryant, H.; Cheung, W.; Decker, K.; Doyle, G.; Mai, V.; McLachlin, C.M.; Niu, J.; Payne, J.; et al. Recent Trends in Breast, Cervical, and Colorectal Cancer Screening Test Utilization in Canada, Using Self-Reported Data from 2008 and 2012. Curr. Oncol. 2015, 22, 297-302. https://doi.org/10.3747/co.22.2690

AMA Style

Major D, Armstrong D, Bryant H, Cheung W, Decker K, Doyle G, Mai V, McLachlin CM, Niu J, Payne J, et al. Recent Trends in Breast, Cervical, and Colorectal Cancer Screening Test Utilization in Canada, Using Self-Reported Data from 2008 and 2012. Current Oncology. 2015; 22(4):297-302. https://doi.org/10.3747/co.22.2690

Chicago/Turabian Style

Major, D., D. Armstrong, H. Bryant, W. Cheung, K. Decker, G. Doyle, V. Mai, C.M. McLachlin, J Niu, J. Payne, and et al. 2015. "Recent Trends in Breast, Cervical, and Colorectal Cancer Screening Test Utilization in Canada, Using Self-Reported Data from 2008 and 2012" Current Oncology 22, no. 4: 297-302. https://doi.org/10.3747/co.22.2690

APA Style

Major, D., Armstrong, D., Bryant, H., Cheung, W., Decker, K., Doyle, G., Mai, V., McLachlin, C. M., Niu, J., Payne, J., & Shukla, N. (2015). Recent Trends in Breast, Cervical, and Colorectal Cancer Screening Test Utilization in Canada, Using Self-Reported Data from 2008 and 2012. Current Oncology, 22(4), 297-302. https://doi.org/10.3747/co.22.2690

Article Metrics

Back to TopTop